Vor Biopharma (VOR) Stock Price, Quote, News & History | Benzinga

Vor Biopharma Inc (VOR) Stock Price, Quote, News & History

VORNASDAQ

Trade with Public

Trade with Public

$23.01

-0.02-0.09%

At close: Aug 17, 5:00 PM EST

$23.01

N/A

After Hours: 5:43 PM EST

Earnings: Q2 2026 Earnings were released on Tue Aug 11th, during market hours

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$22.91

Close

$23.01

Volume / Avg.

791.08K / 1.16M

Day Range

$22.40 - $23.14

52 Wk Range

6.50 - 50.20

Market Cap

$1.36B

P/E Ratio

0.13

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

14.42%

Days to Cover

8.32

Recent Vor Biopharma Inc. News

Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday

Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery forecast. Other companies such as Nexa Resources SA (NEXA) and Moderna Inc (MRNA) also saw gains in today's session.

Avi Kapoor

Microsoft To $500? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. See analyst rating changes and upgrades/downgrades on our analyst ratings page.

Avi Kapoor

What's Behind The Jump In Vor Biopharma Stock?

Shares of Vor Biopharma Inc. (NASDAQ: VOR) are trading higher Friday after pricing a $14.05 private placement of 5.4 million shares.

Alex Perry

Oxford Industries Posts Q4 Results, Joins ADMA Biologics, Vor Biopharma And Other Big Stocks Moving Higher On Friday

U.S. stocks lower, Nasdaq falls 1%. Oxford Industries up 11.2% on strong earnings, raised dividend. Other gains: AGX 35.5%, MSC 24.5%, ADMA 13%, SGML 12.2%, KOD 10.5%, TBN 9.9%, METC 8.8%, U 8.3%, MEOH 7.7%, VOR 6.8%, Kopin Corp.

Avi Kapoor

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-140.09M

Investing Cash Flow (TTM)

-348.99M

Financing Cash Flow (TTM)

404.11M

Free Cash Flow (TTM)

-140.81M

Capital Expenditure (TTM)

-726.00K

Net Change in Cash (TTM)

-84.96M

Analyst Trends and Forecast

2

1

Mar

1

Apr

1

1

May

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$899.26M

PE Ratio (TTM)

0.13

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

784.11%

Earnings Yield % (FWD)

-35.26%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$3.38

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$107.86M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$22.91

Close

$23.01

Volume / Avg.

791.08K / 1.16M

Day Range

$22.40 - $23.14

52 Wk Range

6.50 - 50.20

Market Cap

$1.36B

P/E Ratio

0.13

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

14.42%

Days to Cover

8.32

About

Sector

Health Care

Industry

Biotechnology

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to s...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Vor Biopharma (VOR) stock?

A

You can purchase shares of Vor Biopharma (NASDAQ:VOR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vor Biopharma (VOR) competitors?

A

Other companies in Vor Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Vor Biopharma (VOR) stock?

A

Vor Biopharma has a consensus price target of $26.20.

Q

What is the current price for Vor Biopharma (VOR)?

A

The stock price for Vor Biopharma (NASDAQ: VOR) is $23.01 last updated August 17, 2026 at 5:43 PM EDT.

Q

Does Vor Biopharma (VOR) pay a dividend?

A

There are no upcoming dividends for Vor Biopharma.

Q

When is Vor Biopharma (NASDAQ:VOR) reporting earnings?

A

Vor Biopharma does not have any upcoming earnings scheduled.

Q

Is Vor Biopharma (VOR) going to split?

A

There is no upcoming split for Vor Biopharma.

Q

What sector and industry does Vor Biopharma (VOR) operate in?

A

Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.